|
1
|
Sitarz R, Skierucha M, Mielko J, Offerhaus
GJA, Maciejewski R and Polkowski WP: Gastric cancer: Epidemiology,
prevention, classification, and treatment. Cancer Manag Res.
10:239–248. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Siegel RL, Ward EM and Jemal A:
Global cancer incidence and mortality rates and trends - an update.
Cancer Epidemiol Biomarkers Prev. 25:16–27. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Claassen YHM, de Steur WO, Hartgrink HH,
Dikken JL, van Sandick JW, van Grieken NCT, Cats A, Trip AK, Jansen
EPM, Kranenbarg WMM, et al: Surgicopathological quality control and
protocol adherence to lymphadenectomy in the CRITICS gastric cancer
trial. Ann Surg. Aug 16–2017.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shimada H, Fukagawa T, Haga Y and Oba K:
Does postoperative morbidity worsen the oncological outcome after
radical surgery for gastrointestinal cancers? A systematic review
of the literature. Ann Gastroenterolog Surg. 1:11–23. 2017.
View Article : Google Scholar
|
|
5
|
Jang E, Kim E, Son HY, Lim EK, Lee H, Choi
Y, Park K, Han S, Suh JS, Huh YM, et al: Nanovesicle-mediated
systemic delivery of microRNA-34a for CD44 overexpressing gastric
cancer stem cell therapy. Biomaterials. 105:12–24. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tsai M-M, Wang C-S, Tsai C-Y, Huang H-W,
Chi H-C, Lin Y-H, Lu P-H and Lin K-H: Potential diagnostic,
prognostic and therapeutic targets of microRNAs in human gastric
cancer. Int J Mol Sci. 17:9452016. View Article : Google Scholar
|
|
7
|
Hyrina A, Olmstead AD, Steven P, Krajden
M, Tam E and Jean F: Treatment-induced viral cure of hepatitis C
virus-infected patients involves a dynamic interplay among three
important molecular players in lipid homeostasis: Circulating
microRNA (miR)-24, miR-223, and proprotein convertase
subtilisin/kexin type 9. EBioMedicine. 23:68–78. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pezuk JA, Miller TLA, Bevilacqua JLB, de
Barros ACSD, de Andrade FEM, Macedo E LFA, Aguilar V, Claro ANM,
Camargo AA, Galante PAF, et al: Measuring plasma levels of three
microRNAs can improve the accuracy for identification of malignant
breast lesions in women with BI-RADS 4 mammography. Oncotarget.
8:83940–83948. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sano T, Coit DG, Kim HH, Roviello F,
Kassab P, Wittekind C, Yamamoto Y and Ohashi Y: Proposal of a new
stage grouping of gastric cancer for TNM classification:
International Gastric Cancer Association staging project. Gastric
Cancer. 20:217–225. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using realtime quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hillard JR: Evaluation of state
comprehensive cancer control plans for content related to stomach
cancer. J Clin Oncol. 34 4 suppl:82016. View Article : Google Scholar
|
|
12
|
Harvey RC: Second-line treatments for
advanced gastric cancer: A network meta-analysis of overall
survival using parametric modelling methods. Oncol Ther. 5:53–67.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim W, Kim HH, Han SU, Kim MC, Hyung WJ,
Ryu SW, Cho GS, Kim CY, Yang HK, Park DJ, et al: Korean
Laparo-endoscopic Gastrointestinal Surgery Study (KLASS) Group:
Decreased morbidity of laparoscopic distal gastrectomy compared
with open distal gastrectomy for stage I gastric cancer: Short-term
outcomes from a multicenter randomized controlled trial (KLASS-01).
Ann Surg. 263:28–35. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Haverkamp L, Ruurda JP, Offerhaus GJ,
Weijs TJ, van der Sluis PC and van Hillegersberg R: Laparoscopic
gastrectomy in Western European patients with advanced gastric
cancer. Eur J Surg Oncol. 42:110–115. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hsu KW, Fang WL, Huang KH, Huang TT, Lee
HC, Hsieh RH, Chi CW and Yeh TS: Notch1 pathway-mediated
microRNA-151-5p promotes gastric cancer progression. Oncotarget.
7:38036–38051. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lynch SM, McKenna MM, Walsh CP and McKenna
DJ: miR-24 regulates CDKN1B/p27 expression in prostate cancer.
Prostate. 76:637–648. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ye SB, Zhang H, Cai TT, Liu YN, Ni JJ, He
J, Peng JY, Chen QY, Mo HY, Jun-Cui T, et al: Exosomal miR-24-3p
impedes T-cell function by targeting FGF11 and serves as a
potential prognostic biomarker for nasopharyngeal carcinoma. J
Pathol. 240:329–340. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen LG, Xia YJ and Cui Y: Upregulation of
miR-101 enhances the cytotoxic effect of anticancer drugs through
inhibition of colon cancer cell proliferation. Oncol Rep.
38:100–108. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang H, Duan J, Qu Y, Deng T, Liu R,
Zhang L, Bai M, Li J, Ning T, Ge S, et al: Onco-miR-24 regulates
cell growth and apoptosis by targeting BCL2L11 in gastric cancer.
Protein Cell. 7:141–151. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen DL, Ju HQ, Lu YX, Chen LZ, Zeng ZL,
Zhang DS, Luo HY, Wang F, Qiu MZ, Wang DS, et al: Long non-coding
RNA XIST regulates gastric cancer progression by acting as a
molecular sponge of miR-101 to modulate EZH2 expression. J Exp Clin
Cancer Res. 35:1422016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Soifer HS, Salunga RC, Harris TG, Ramirez
J, Gogoi P, Wang Y, Sepehri S, Handique K and Schnabel CA: Gene
expression profiling for cancer classification in circulating tumor
cells. In: Proceedings of the 107th Annual Meeting of the American
Association for Cancer Research. Cancer Res. 76 14 Suppl:Abst 1391.
2016. View Article : Google Scholar
|
